No Data
Is Generation Bio (NASDAQ:GBIO) In A Good Position To Deliver On Growth Plans?
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Generation Bio Third Quarter 2024 Earnings: Beats Expectations
CCORF Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $9
Promising Pipeline and Strong Financials Affirm Buy Rating for Generation Bio
Generation Bio GAAP EPS of -$0.23, Revenue of $7.55M